Syria – Allegations of GSK corruption spread to Syria: Fidelity

July 27, 2014 6:12 pm0 commentsViews: 24
Source : Google

Source : Google

  • GlaxoSmithKline and its distributor have been accused of paying bribes to secure business in Syria, as reported Fidelity Thursday.
  • The British drugmaker said that it was investigating the latest allegations, which date back to 2010.
  • The company is currently under investigation in China concerning allegations that it paid up to 3 billion yuan in kickbacks to doctors in the country, while the drugmaker has also been accused of corruption in Poland, Iraq, Jordan and Lebanon.
  • According to the whistleblower, incentives, such as cash payments to promote Panadol, were given to doctors, dentists, pharmacists and government officials to win tenders and obtain improper business advantages.
  • The whistleblower also accused GlaxoSmithKline of engaging in apparent Syrian export control violations, including an alleged smuggling scheme to ship the drug component pseudoephedrine to Iran from Syria via Iraq.
  • The company remains under investigation by the UK’s Serious Fraud Office and the US Department of Justice regarding its foreign business practices.

[Source : firstwordpharma]

Comment this Post

You must be logged in to post a comment.

Recent Comments